LLY Lilly(Eli) & Company

  1. Stocks
  2. Healthcare
  3. NYSE: LLY

Price (delayed)

$1,115.7

Market cap

$1.05T

P/E Ratio

37.39

Dividend/share

$6.69

EPS

$29.84

Enterprise value

$1.1T

?
Relative Growth: Rel. Growth: 99
Relative Strength: Rel. Strength: 65
Relative Valuation: Rel. Valuation: 39
Relative Profitability: Rel. Profitability: 99

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of ...

Highlights
The net income has soared by 94% YoY and by 6% from the previous quarter
The EPS has soared by 94% YoY and by 6% QoQ
The quick ratio has increased by 28% year-on-year but it has declined by 6% since the previous quarter
Lilly(Eli)'s debt has increased by 38% YoY and by 27% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.lilly.com
Peers: BMY MRK JNJ PFE

Key stats

What are the main financial stats of LLY

LLY stock price

How has the Lilly(Eli) stock price performed over time
Intraday
-0.65%
1 week
-2.93%
1 month
-8.17%
1 year
47.52%
YTD
3.82%
QTD
-6.98%

Financial performance

How have Lilly(Eli)'s revenue and profit performed over time
Revenue
$79.67B
Gross profit
$66.44B
Operating income
$33.96B
Net income
$26.71B
Gross margin
83.4%
Net margin
33.5%
LLY's operating income has surged by 95% year-on-year and by 7% since the previous quarter
The net income has soared by 94% YoY and by 6% from the previous quarter
The company's gross profit has surged by 51% YoY and by 11% QoQ
Lilly(Eli)'s revenue has increased by 50% YoY and by 10% from the previous quarter

Price vs fundamentals

How does LLY's price correlate with its fundamentals

Growth

What is Lilly(Eli)'s growth rate over time

Valuation

What is Lilly(Eli) stock price valuation
LLY P/E details
P/E
37.39
P/B
31.01
P/S
12.5
EV/EBIT
32.63
EV/EBITDA
30.71
EV/Sales
13.76
The EPS has soared by 94% YoY and by 6% QoQ
The P/E is 40% below the 5-year quarterly average of 62.6 and 4.6% below the last 4 quarters average of 39.2
The equity has surged by 85% year-on-year and by 9% since the previous quarter
LLY's P/B is 23% below its 5-year quarterly average of 40.2 and 4.3% below its last 4 quarters average of 32.4
Lilly(Eli)'s revenue has increased by 50% YoY and by 10% from the previous quarter
The stock's price to sales (P/S) is 7% less than its 5-year quarterly average of 13.4 and 2.3% less than its last 4 quarters average of 12.8

Efficiency

How efficient is Lilly(Eli) business performance
The ROIC has grown by 47% YoY
The ROA has grown by 38% YoY but it has contracted by 3.1% from the previous quarter
The ROS has increased by 33% YoY but it has decreased by 2.1% QoQ
The company's return on equity fell by 9% QoQ but it rose by 4.9% YoY

Dividends

What is LLY's dividend history
Dividend details
DPS
$6.69
Dividend yield
0.6%
Payout ratio
22.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Lilly(Eli) financials performed over time
LLY's total assets is 31% greater than its total liabilities
LLY's total assets is up by 41% year-on-year and by 22% since the previous quarter
Lilly(Eli)'s total liabilities has increased by 31% YoY and by 27% from the previous quarter
Lilly(Eli)'s debt is 62% more than its equity
The equity has surged by 85% year-on-year and by 9% since the previous quarter
Lilly(Eli)'s debt has increased by 38% YoY and by 27% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.